Fact CheckerSign in

NCT05734313Recruiting

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults With Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 30 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
94 (estimated)
First submitted
2 Feb 2023
Start date
31 Mar 2023
Primary completion date
Dec 2027
Lead sponsor
Albert Einstein College of Medicine
NCT number
NCT05734313

What you commit to

  • Study type: Interventional
  • Planned participants: 94
  • From 31 Mar 2023 to the primary completion date, Dec 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT; (6) temporary exclusion for recent initiation of psychotropic medication - must be on a stable dose for 6 weeks prior to enrollment.

Other illness

  • Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm

Lab values

  • Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study

Other

  • Developmental or sensory disability interfering with participation
  • Current pregnancy

Who the study is looking for

  • Type 1 diabetes (T1D) duration ≥ 6 months
  • 18-64 years old
  • English- or Spanish-speaking
  • Anxiety or depressive mood disorder as per structured diagnostic interview.

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Boston University
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Albert Einstein College of Medicine
Coordinator of this site? Confirm its status
The BronxUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.